SK286501B6 - Použitie alfa-halogénakryloyl-distamycínového derivátu na výrobu liečiva na liečenie nádorov - Google Patents

Použitie alfa-halogénakryloyl-distamycínového derivátu na výrobu liečiva na liečenie nádorov Download PDF

Info

Publication number
SK286501B6
SK286501B6 SK1600-2002A SK16002002A SK286501B6 SK 286501 B6 SK286501 B6 SK 286501B6 SK 16002002 A SK16002002 A SK 16002002A SK 286501 B6 SK286501 B6 SK 286501B6
Authority
SK
Slovakia
Prior art keywords
amino
methyl
carbonyl
pyrrol
gsh
Prior art date
Application number
SK1600-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK16002002A3 (sk
Inventor
Maria Cristina Rosa Geroni
Paolo Cozzi
Italo Beria
Original Assignee
Pharmacia Italia S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S. P. A. filed Critical Pharmacia Italia S. P. A.
Publication of SK16002002A3 publication Critical patent/SK16002002A3/sk
Publication of SK286501B6 publication Critical patent/SK286501B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
SK1600-2002A 2000-05-08 2001-04-19 Použitie alfa-halogénakryloyl-distamycínového derivátu na výrobu liečiva na liečenie nádorov SK286501B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011059.3A GB0011059D0 (en) 2000-05-08 2000-05-08 Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
PCT/EP2001/004470 WO2001085144A2 (en) 2000-05-08 2001-04-19 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione

Publications (2)

Publication Number Publication Date
SK16002002A3 SK16002002A3 (sk) 2003-04-01
SK286501B6 true SK286501B6 (sk) 2008-11-06

Family

ID=9891173

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1600-2002A SK286501B6 (sk) 2000-05-08 2001-04-19 Použitie alfa-halogénakryloyl-distamycínového derivátu na výrobu liečiva na liečenie nádorov

Country Status (29)

Country Link
US (1) US7030089B2 (zh)
EP (1) EP1280527B1 (zh)
JP (1) JP2003532669A (zh)
KR (1) KR100776184B1 (zh)
CN (1) CN1258362C (zh)
AR (1) AR029518A1 (zh)
AT (1) ATE300944T1 (zh)
AU (2) AU2001260227B2 (zh)
BR (1) BR0110628A (zh)
CA (1) CA2409664C (zh)
CZ (1) CZ300791B6 (zh)
DE (1) DE60112423T2 (zh)
DK (1) DK1280527T3 (zh)
EA (1) EA007506B1 (zh)
EE (1) EE200200605A (zh)
ES (1) ES2244618T3 (zh)
GB (1) GB0011059D0 (zh)
HK (1) HK1054193B (zh)
HU (1) HUP0301882A2 (zh)
IL (2) IL152388A0 (zh)
MX (1) MXPA02010962A (zh)
NO (1) NO20025303D0 (zh)
NZ (1) NZ522234A (zh)
PL (1) PL201289B1 (zh)
PT (1) PT1280527E (zh)
SK (1) SK286501B6 (zh)
TW (1) TWI284643B (zh)
WO (1) WO2001085144A2 (zh)
ZA (1) ZA200208531B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
IT1318696B1 (it) 2000-09-15 2003-08-27 Pharmacia & Upjohn Spa Coniugati di glutatione con derivati della distamicina ad attivita'antitumorale.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
KR100968657B1 (ko) * 2002-04-02 2010-07-06 네르비아노 메디칼 사이언시스 에스.알.엘. 치환된 아크릴로일 디스타마이신 유도체 및 방사선요법을포함하는 조합 종양 치료법
PL3362056T3 (pl) * 2015-10-15 2021-09-27 Advanced Biodesign Związki aminotioestrowe lub ich farmaceutycznie dopuszczalne sole do stosowania w leczeniu nowotworu

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
EP0265719B1 (en) 1986-10-07 1991-03-06 Boehringer Mannheim Italia S.P.A. Pharmaceutical compositions having antineoplastic activity
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
JP2919867B2 (ja) 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
IT1272234B (it) 1994-05-02 1997-06-16 Consiglio Nazionale Ricerche Derivati glutationici delle antracicline e procedimento per ottenerli.
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5880097A (en) 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
AU1596097A (en) 1996-02-02 1997-08-22 Pharmacia & Upjohn S.P.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9610079D0 (en) 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9816652D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816653D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione

Also Published As

Publication number Publication date
NZ522234A (en) 2004-09-24
EP1280527B1 (en) 2005-08-03
KR20030019371A (ko) 2003-03-06
WO2001085144A2 (en) 2001-11-15
CA2409664A1 (en) 2001-11-15
US7030089B2 (en) 2006-04-18
DE60112423D1 (de) 2005-09-08
ES2244618T3 (es) 2005-12-16
HK1054193A1 (en) 2003-11-21
ATE300944T1 (de) 2005-08-15
AR029518A1 (es) 2003-07-02
HUP0301882A2 (hu) 2003-09-29
HK1054193B (zh) 2007-02-02
CZ300791B6 (cs) 2009-08-12
GB0011059D0 (en) 2000-06-28
CZ20023629A3 (cs) 2003-03-12
US20030207794A1 (en) 2003-11-06
ZA200208531B (en) 2003-10-22
KR100776184B1 (ko) 2007-11-16
IL152388A0 (en) 2003-05-29
SK16002002A3 (sk) 2003-04-01
EP1280527A2 (en) 2003-02-05
NO20025303L (no) 2002-11-05
WO2001085144A3 (en) 2002-05-16
EA200201184A1 (ru) 2003-04-24
IL152388A (en) 2008-04-13
EE200200605A (et) 2004-04-15
AU2001260227B2 (en) 2005-10-27
CA2409664C (en) 2010-01-12
CN1427719A (zh) 2003-07-02
CN1258362C (zh) 2006-06-07
BR0110628A (pt) 2003-03-18
TWI284643B (en) 2007-08-01
PL201289B1 (pl) 2009-03-31
EA007506B1 (ru) 2006-10-27
DK1280527T3 (da) 2005-10-17
PT1280527E (pt) 2005-10-31
MXPA02010962A (es) 2003-03-27
NO20025303D0 (no) 2002-11-05
PL365831A1 (en) 2005-01-10
AU6022701A (en) 2001-11-20
JP2003532669A (ja) 2003-11-05
DE60112423T2 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
US5541230A (en) Therapeutic polyamines
CA2390231A1 (en) Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
US11160770B2 (en) Compounds, compositions and methods for treating oxidative DNA damage disorders
SK286501B6 (sk) Použitie alfa-halogénakryloyl-distamycínového derivátu na výrobu liečiva na liečenie nádorov
AU2001260227A1 (en) Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
EP2688566A2 (en) Anticancer therapeutic agents
AU2002323368A1 (en) Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
WO2003018014A2 (en) Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
US20030187046A1 (en) Pharmaceutical composition for inhibiting the growth of viruses and cancers
WO2002041891A2 (en) Hiv treatment with benzimidazoles
CA2978965C (en) 1-((n-(2benzyl-phenyl)-carbamoyl-methyl)-carbamoyl)-naphthalene as anticancer therapeutic agent
US20230157978A1 (en) Ape/ref1 inhibitors for the treatment of cancer
WO2009062128A2 (en) Combination drug therapy for the treatment of cancer
US20190247397A1 (en) Combinatory treatment strategies of cancer based on rna polymerase i inhibition
MXPA00011360A (en) Compositions for the treatment of hiv and other viral infections

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110419